Followers | 696 |
Posts | 31840 |
Boards Moderated | 8 |
Alias Born | 03/16/2014 |
Friday, March 02, 2018 1:15:04 PM
"With completion of the CanniMed acquisition anticipated shortly, the Company will be able to accelerate the build up of its medical science division. The Company intends for CanniMed's Saskatchewan operations to become Aurora`s Medical Cannabis Centre of Excellence. Dr. Morris and Dr. Narine will co-ordinate efforts and work closely with the CanniMed science team on new medical initiatives.
Management commentary
"These key appointments reflect our commitment to a science-based approach to innovation, product and technology development," said Terry Booth, CEO. "Our intention is to develop a strong pipeline of new, higher-margin revenue streams to capitalize on the tremendous opportunity in the medical cannabis and adult consumer use markets. Science and innovation are cornerstones of our global growth strategy, and with Shane and Kelly we now have highly experienced leadership for the science division. Furthermore, once completed, the CanniMed acquisition will provide a strong foundation to build our medical science division on, and help further differentiate and diversify our product offering."
Dr. Morris added "I am thrilled to join the Aurora team, a frontrunner in the cannabis industry in Canada and globally. I look forward to the exciting opportunity to develop and launch new products for existing and new markets across the globe, and help Aurora's continued rapid growth."
Dr. Narine added, "To join the innovation leader in this sector, and help develop new offerings with positive human health outcomes, as well as work on the early-stage development of new technologies for a market that has proven to be exceptionally receptive, is extremely exciting. I look forward to working with the Aurora team and helping to advance our scientific leadership in the sector."
https://investor.auroramj.com/press-releases/
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM